Results 111 to 120 of about 46,480 (224)

GPIHBP1 on oligodendrocytes binds lipoprotein lipase within the human brain. [PDF]

Proc Natl Acad Sci U S A
Liu M, Hung M, Kozlov E, Hung M, Colaço-Gaspar M, Roy S, Tu Y, Magaki SD, Williams CK, Andaloussi Mäe M, Johnson ECB, Siegel RW, Konrad RJ, Ploug M, Betsholtz C, Beigneux AP, He L, Fong LG, Young SG.   +18 more
europepmc   +1 more source

Metabolic Regulation of Macrophages in Health and Disease

MedComm, Volume 7, Issue 8, August 2026.
Extracellular metabolites drive metabolic rewiring of glucose, lipid, and amino acid pathways in macrophages, steering their polarization toward pro‐ or anti‐inflammatory phenotypes and shaping a wide range of disease processes. Macrophages from different tissues display distinct metabolic signatures, and therapeutic strategies that target these ...
Shan Huang, Yu Zhang, Jiali Min, Jiahui Yang, Yuchen Li, Hao Zhang, Shanshan Liu   +6 more
wiley   +1 more source

Cardiac Metabolomic Alterations in Diabetes: Interplay with Lipoprotein Lipase-A Systematic Review. [PDF]

Int J Mol Sci
Gu J, Han X, Chen X, Lyu A, Cheung KCP.
europepmc   +1 more source

Convergent digestive adaptation to resource limitation in an insular lizard across a microgeographic archipelago

Journal of Animal Ecology, Volume 95, Issue 8, Page 1372-1385, August 2026.
Replicated mainland–islet populations of the Skyros wall lizard reveal consistent divergence in digestive physiology, including gut morphology, passage time, digestive efficiency and enzyme activity. These results show how ecological variation in resource availability can shape digestive performance across populations in insular environments.
Aikaterini Reppa, Foteini Paraskevopoulou, Kyriaki Papageorgiou, Giannis Tounias, Panayiota Santikou, Aristeidis Parmakelis, Efstratios D. Valakos, Panayiotis Pafilis, Kostas Sagonas   +8 more
wiley   +1 more source

Preheparin Serum Lipoprotein Lipase Mass as a Coronary Risk Factor in Patients With Chronic Kidney Disease. [PDF]

Cardiol Res
Hitsumoto T.
europepmc   +1 more source

Imaging the ANGPTL3/8-mediated regulation of lipoprotein lipase in the heart. [PDF]

J Lipid Res, 2023
Yang Y, Jung H, Konrad RJ, Fong LG, Young SG.   +4 more
europepmc   +1 more source

Survodutide for the Treatment of Obesity Disease in Japanese Participants: Rationale, Design and Baseline Characteristics of the Phase 3 SYNCHRONIZE‐JP Trial

Diabetes, Obesity and Metabolism, Volume 28, Issue 8, Page 6595-6606, August 2026.
ABSTRACT Aims There is an unmet need for effective pharmacotherapy for obesity disease management in Japan. Survodutide is a novel glucagon receptor/glucagon‐like peptide‐1 receptor (GLP‐1R) dual agonist with the potential to induce greater weight reductions than GLP‐1R mono‐agonists. We report the design and baseline participant characteristics of the
Koutaro Yokote, Toshimasa Yamauchi, Yasushi Fukushima, Yoji Takatsuka, Marie Kato, Shijia Yan, Takayoshi Inoue, Luiza Borowska, Martina Brueckmann, Wataru Ogawa, on behalf of the SYNCHRONIZE‐JP Trial Investigators   +10 more
wiley   +1 more source

Reversibly reduced lipoprotein lipase in APOA5 c.553G>T-related hypertriglyceridemia successfully treated with pemafibrate. [PDF]

Endocrinol Diabetes Metab Case Rep
Miyauchi S, Utsunomiya Y, Okamoto M, Akesaka K, Ono K, Hara Y, Miyazaki M, Nakaguchi H, Miyake T, Furukawa S, Ebisui O, Hiasa Y, Matsuura B.   +12 more
europepmc   +1 more source

GIP in Cardiovascular and Kidney Disease: From Physiology to Pharmacology

Diabetes, Obesity and Metabolism, Volume 28, Issue 8, Page 6509-6532, August 2026.
ABSTRACT Aims To provide a comprehensive overview of the cardiovascular and renal effects of glucose‐dependent insulinotropic polypeptide (GIP) by integrating its physiological role with recent human trial data on tirzepatide, the first dual GIP and glucagon‐like peptide‐1 (GLP‐1) receptor agonist.
Michelantonio De Fano, Line L. Haurum, Christine R. Schwarz, Francesca Porcellati, Andreas Andersen   +4 more
wiley   +1 more source

The Ongoing Utility of lipoprotein lipase activity in diagnosing familial Chylomicronemia Syndrome. [PDF]

Biochem Biophys Rep
Fariña G, Barchuk M, Sleiman A, Castellanos Pinedo A, Gutierrez Restrepo J, Zago V, Nogueira JP, Berg G.   +7 more
europepmc   +1 more source